Action Akers Biosciences - AKER

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

2,47

Prix Achat

2,41

Prix Vente

2,50

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

125,723M

Clôture Veille

2,47

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

50 900 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-11,27

Bénéfice par action (BPA)

-0,16

Chiffre d'affairess

Bénéfice net

-8,22M

Secteur

In Vitro,in Vivo Diagnostics

Industrie

In Vitro,in Vivo Diagnostics

Site Web

www.mymd.com

Siège social

Baltimore, Maryland, USA

Fondé

Contango Announces the Appointment of Two New Directors

FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF...

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol "MYMD" Upon Closing, the Combined Company...

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial

Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage...

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

Chaired by Katharine Whartenby, Ph.D., members include experts in molecular medicine, aging, pathology and oncology Akers Biosciences, Inc...

Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

Akers Biosciences, Inc (Nasdaq: AKER), today announced that it has scheduled its general meeting of shareholders (the "Meeting”) to vote on the...

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Data from the translationally relevant study reported ability of MYMD-1 to inhibit key biomarkers associated with fibrotic diseases including...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AKER - Frequently Asked Questions (FAQ)

What is the current Akers Biosciences share price?

The current share price of Akers Biosciences is US$ 2,47

How many Akers Biosciences shares are in issue?

Akers Biosciences has 50 900 000 shares in issue

What is the market cap of Akers Biosciences?

The market capitalisation of Akers Biosciences is USD 125,72M

What is the 1 year trading range for Akers Biosciences share price?

Akers Biosciences has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Akers Biosciences?

The price to earnings ratio of Akers Biosciences is -11,27

What is the reporting currency for Akers Biosciences?

Akers Biosciences reports financial results in USD

What is the latest annual profit for Akers Biosciences?

The latest annual profit of Akers Biosciences is USD -8,22M

What is the registered address of Akers Biosciences?

The registered address for Akers Biosciences is 855 N. WOLFE STREET, SUITE 601, BALTIMORE, MARYLAND, 21205

What is the Akers Biosciences website address?

The website address for Akers Biosciences is www.mymd.com

Which industry sector does Akers Biosciences operate in?

Akers Biosciences operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ENVBEnveric Biosciences Inc	US$ 2,27 (92,37%)	135,42M
PITAHeramba Electric PLC	US$ 0,694 (88,08%)	100,74M
PRCHPorch Group Inc	US$ 6,60 (74,14%)	32,03M
MULNMullen Automotive Inc	US$ 4,035 (70,97%)	94,61M
RENBRenovaro Inc	US$ 1,19 (53,95%)	31,84M
VEROVenus Concept Inc	US$ 0,326949 (-39,45%)	1,93M
FLYWFlywire Corporation	US$ 11,045 (-37,39%)	24,73M
ILAGIntelligent Living Application Group Inc	US$ 0,5444 (-33,61%)	476,4k
ONVOOrganovo Holdings Inc	US$ 0,8499 (-33,08%)	49,99M
GERNGeron Corp	US$ 1,605 (-32,28%)	92,24M
NVDANVIDIA Corporation	US$ 131,28 (3,67%)	328,62M
TRNRInteractive Strength Inc	US$ 1,2401 (30,58%)	157,21M
LCIDLucid Group Inc	US$ 2,255 (-13,60%)	156,06M
SMCISuper Micro Computer Inc	US$ 51,08 (12,17%)	140,93M
ENVBEnveric Biosciences Inc	US$ 2,27 (92,37%)	134,34M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Akers Biosciences Inc (AKER)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Akers Biosciences Inc

AKER Dernières nouvelles

Contango Announces the Appointment of Two New Directors

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

Akers Biosciences Responds to Erroneous Earnings Call Press Release

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent

REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals

AKER - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Akers Biosciences Inc (AKER) Cours

Akers Biosciences Inc (AKER)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Akers Biosciences Inc

AKER Dernières nouvelles

Contango Announces the Appointment of Two New Directors

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

Akers Biosciences Responds to Erroneous Earnings Call Press Release

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent

REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals

AKER - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS